Biosimilars

The AJMC® Biosimilars compendium is a comprehensive resource for news and expert insights into these biological products, including clinical research, patent and legal news, and regulatory updates.

Latest News

Drug Prices to Continue Upward Trend Even as Biosimilars Enter the Market
Drug Prices to Continue Upward Trend Even as Biosimilars Enter the Market

January 27th 2023

Multiple adalimumab biosimilars will hit the US market in 2023, but the drug is still projected to have the largest price increase for the calendar year starting July 1.

Sintilimab Plus Bevacizumab Biosimilar Improves Response Rates, Depth of Response in HCC
Sintilimab Plus Bevacizumab Biosimilar Improves Response Rates, Depth of Response in HCC

January 21st 2023

With 2 Biosimilars Available, Use Remains Low Among Ophthalmologists
With 2 Biosimilars Available, Use Remains Low Among Ophthalmologists

January 14th 2023

PBMs Announce 2023 Coverage Plans for Adalimumab Biosimilars
PBMs Announce 2023 Coverage Plans for Adalimumab Biosimilars

January 1st 2023

Video Series
Video Interviews
Podcasts

More News

© 2023 MJH Life Sciences
AJMC®
All rights reserved.